当前位置:首页 - 行情中心 - 亚虹医药-U(688176) - 财务分析

亚虹医药-U

(688176)

  

流通市值:34.01亿  总市值:51.24亿
流通股本:3.78亿   总股本:5.70亿

亚虹医药-U(688176)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-0.86亿元,每股收益-0.15元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益188925.57万元,未分配利润-151214.59万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产216156.32万元,负债27230.75万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入61,101,125.72201,562,432.59138,951,629.0380,493,424.46
营业总成本152,883,339.26609,000,649.86422,331,119.09275,421,295.92
营业利润-85,719,477.84-383,805,943.59-268,659,981.92-184,430,587.26
利润总额-86,391,242.73-386,795,826.88-271,557,522.32-184,702,091.44
净利润-86,341,679.22-386,000,059.67-271,342,070.94-184,325,904.69
其他综合收益-52,203.72-5,208,757.06-2,291,721.15-3,994,091.88
综合收益总额-86,393,882.94-391,208,816.73-273,633,792.09-188,319,996.57
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,780,132,063.571,530,945,418.211,598,463,174.922,089,406,719.53
非流动资产合计381,431,167.4692,046,485.58715,379,353.25354,605,395.25
资产总计2,161,563,230.972,222,991,903.792,313,842,528.172,444,012,114.78
流动负债合计221,202,487.62197,059,830.76177,890,199.89206,289,585.05
非流动负债合计51,104,994.1955,558,274.5356,303,371.3853,578,993.36
负债合计272,307,481.81252,618,105.29234,193,571.27259,868,578.41
归属于母公司股东权益合计1,890,799,054.311,969,405,336.092,078,328,413.082,182,663,932
股东权益合计1,889,255,749.161,970,373,798.52,079,648,956.92,184,143,536.37
负债和股东权益合计2,161,563,230.972,222,991,903.792,313,842,528.172,444,012,114.78
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计61,061,157.83195,899,049.99128,580,141.1972,412,351.79
经营活动现金流出小计171,418,315.44620,849,902.16453,739,827.29315,254,586.9
经营活动产生的现金流量净额-110,357,157.61-424,950,852.17-325,159,686.1-242,842,235.11
投资活动现金流入小计1,534,792,114.972,395,262,459.833,401,030,620.391,855,459,327.26
投资活动现金流出小计1,215,228,607.381,598,008,544.962,957,271,644.361,542,138,091.47
投资活动产生的现金流量净额319,563,507.59797,253,914.87443,758,976.03313,321,235.79
筹资活动现金流入小计77,290,00066,200,00036,500,00036,500,000
筹资活动现金流出小计41,572,485.23143,210,871.59105,856,986.4432,112,810.31
筹资活动产生的现金流量净额35,717,514.77-77,010,871.59-69,356,986.444,387,189.69
汇率变动对现金及现金等价物的影响20,225.13-1,954,293.65-232,028.76-7,577.18
现金及现金等价物净增加额244,944,089.88293,337,897.4649,010,274.7374,858,613.19
期末现金及现金等价物余额865,579,055.99620,634,966.11376,307,343.38402,155,681.84
最新报告期:2025-04-23
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西南证券杜向阳,汤泰萌-0.75-0.76-0.712025-04-23
太平洋周豫,霍亮-0.63-0.57-0.352025-04-23
中信证券陈竹,唐寅灏,韩世通-0.53-0.37-0.152025-04-22
财通证券华挺,赵千,张文录-0.36-0.100.172025-04-21
TOP↑